BIO-TECHNE Corp
TECH- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000842023
No open-market purchases or sales by BIO-TECHNE Corp insiders were filed in the last 90 days; 597 institutions reported holding it in 13F filings for Q2 2026, worth $12.3B in total; 3 superinvestors hold it, including Maverick Capital and Weitz Investment Management.
Q1 2026 vs. Q4 2025
How the institutions holding BIO-TECHNE Corp changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 586 | 10 | 585 | +9 |
| Shares | 171.9M | 20.1M | 177.4M | +25.6M (+16.9%) |
| Value | $10.1B | $1.18B | $9.29B | +$359.2M (+4.0%) |
10 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (73)
Institutions that held BIO-TECHNE Corp at the end of Q1 2026 but not at the end of Q4 2025.
Sold out (64)
Institutions that held BIO-TECHNE Corp at the end of Q4 2025 and filed for Q1 2026 without it.
Not filed for Q1 2026 yet (10)
Institutions that held BIO-TECHNE Corp at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 17,810,878 | $1.05B |
| Norges Bank | 1,691,780 | $99.5M |
| Iron Triangle Partners LP | 467,409 | $27.5M |
| Comerica Bank | 105,481 | $6.20M |
| CIBC World Markets Corp | 16,268 | $956.7K |
| David Loasby | 5,260 | $350.1K |
| CIBC Private Wealth Group, LLC | 4,374 | $257.2K |
| Global Retirement Partners, LLC | 2,005 | $117.9K |
| DV Equities, LLC | 218 | $12.8K |
| ORG Partners LLC | 16 | $938 |